Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-11

FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for cetirizine hydrochloride from Amneal Pharmaceuticals LLC, authorizing modifications to the product under ANDA 090766…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetirizine hydrochloride (Cetirizine hydrochloride)

Snippet

SUPPL AP for CETIRIZINE HYDROCHLORIDE (CETIRIZINE)